Saturday 17 October 2026 Export CORT’s income statement to Excel — free account

Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $761.4 million, up 12.8% from fiscal 2024. In the quarter to June 2026, revenue grew 31.7%, EPS grew 21.2% and free cash flow fell 29.9%, each against the same quarter a year earlier. Revenue growth for ten consecutive years; insiders bought in the last twelve months.

110.16 3.21 −2.83%

Follow CORT

Alert me

Market cap: $12.3B
P/E: 212×
Fwd P/E: 139×
Dividend yield: —
F-score: 4/9
Altman Z: 14.11
Beneish M: −2.76
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	16.47%	14.79%	7.07%	8.08%
Piotroski F-Score Full definition →		5	4	5	5
ROA Full definition →		13.02%	11.71%	5.62%	6.41%
ROIC Full definition →		19.01%	9.98%	(1.71%)	1.01%
Return on Tangible Assets Full definition →		28.22%	30.56%	16.67%	18.63%
Average Days of Receivables Full definition →		34.29	28.66	18.54	33.79
Free Cash Flow per Share Full definition →		1.58	1.37	1.15	1.01
Free Cash Flow Full definition →		163.32	141.79	120.15	106.92
Capital Expenditures Full definition →		(0.28)	(0.21)	(0.31)	(2.78)
Other line items
Cash ROIC Full definition →		15.42%	13.83%	12.31%	10.54%
Accounts Receivable Turnover Full definition →		11.46	13.39	15.25	11.74
Accounts Payable Turnover Full definition →		0.50	0.47	0.44	0.73
Inventory Turnover Full definition →		1.31	1.03	0.99	1.11
Average Days of Payables Full definition →		939.11	1,137.56	903.37	386.38
Days of Inventory on Hand Full definition →		336.67	361.93	349.62	341.68
Tax Rate Full definition →		0.20	0.50	2.90	1.09
Research and Development Expense of Revenue Full definition →		35.13%	33.48%	33.86%	30.56%
Selling, General and Administrative Expense of Revenue Full definition →		54.22%	58.93%	65.46%	66.98%
Share Based Compensation of Revenue Full definition →		10.86%	11.10%	11.14%	11.57%
Operating CF/Net income Full definition →		1.56	1.45	2.58	2.02
Depreciation/Fixed assets Full definition →		(4.33)	(1.70)	(0.97)	(0.52)
Capex/Depreciation Full definition →		0.03	0.07	0.10	1.04
Revenue per Share Full definition →		7.16	7.33	7.36	7.88
Operating CF per Share Full definition →		1.58	1.37	1.15	1.04
Capex per Share Full definition →		0.00	0.00	0.00	(0.03)
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly